ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

NAILA HAROON M.D.

1760 COUNTY ROAD J SAUNDERS MEDICAL CENTER

Wahoo | Nebraska | 68066

(402) 443-4191

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 198

$310K Total Retail Price of All Prescriptions

Rank: 106 out of 198

383 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 6,060 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
AMLODIPINE BESYLATE 382 349 1 4
OMEPRAZOLE 356 322 2 3
LEVOTHYROXINE SODIUM 323 268 3 1
SIMVASTATIN 278 248 4 2
POTASSIUM CHLORIDE 265 232 5 9
HYDROCODONE-ACETAMINOPHEN 263 199 S3 6 8
FUROSEMIDE 218 191 7 5
LISINOPRIL 189 161 8 6
MELOXICAM 187 133 9 30
WARFARIN SODIUM 176 158 10 7
CITALOPRAM HBR 159 141 11 20
METOPROLOL SUCCINATE 133 113 12 11
AMLODIPINE BESYLATE-BENAZEPRIL 114 106 13 99
METFORMIN HCL 109 87 14 13
GABAPENTIN 108 79 15 14
BENAZEPRIL HCL 108 99 15 45
METHYLPREDNISOLONE 86 64 17 167
ATORVASTATIN CALCIUM 80 54 18 12
LOSARTAN POTASSIUM 79 70 19 18
TRAMADOL HCL 78 39 20 15
METOPROLOL TARTRATE 74 68 21 10
OXYBUTYNIN CHLORIDE ER 72 53 22 109
POLYETHYLENE GLYCOL 3350 72 58 22 41
NAMENDA 70 70 24 33
LEVOFLOXACIN 70 56 24 81
ZOLPIDEM TARTRATE 68 49 26 22
DONEPEZIL HCL 65 61 27 28
METFORMIN HCL ER 62 58 28 64
ATENOLOL 60 55 29 17
TAMSULOSIN HCL 60 60 29 27
ALENDRONATE SODIUM 59 53 31 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 44 32 38
RANITIDINE HCL 57 29 33 54
NIASPAN 57 29 33 138
GLIPIZIDE XL 52 36 35 152
NYSTATIN 51 48 36 148
AMOX TR-POTASSIUM CLAVULANATE 50 42 37 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.